Thyroid Eye Disease

Adults receiving teprotumumab for the treatment of thyroid eye disease experience a similar number of hearing-related adverse events as those not treated with teprotumumab, according to new data.

In this Healio video, Jeff Todd, president and CEO at Prevent Blindness, discusses the organization’s art therapy program, which was created to help patients with thyroid eye disease cope with feelings of isolation, anxiety and depression.

Need to catch up on anything from this year’s Clinical Trials at the Summit? Here are some of Healio’s latest videos from the meeting.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Shankar Ramaswamy, MD, of Kriya Therapeutics highlights the company’s gene therapy programs for geographic atrophy and thyroid eye disease.

A 77-year-old man was referred to the neuro-ophthalmology clinic at Tufts/New England Eye Center for bilateral optic nerve swelling.